Advertisement
Advertisement

BLTE

BLTE logo

Belite Bio, Inc - ADR

173.31
USD
Sponsored
+3.34
+1.97%
Feb 02, 15:59 UTC -5
Closed
exchange

Pre-Market

172.14

-1.17
-0.68%

BLTE Earnings Reports

Positive Surprise Ratio

BLTE beat 5 of 13 last estimates.

38%

Next Report

Date of Next Report
Mar 16, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.55
Implied change from Q3 25 (Revenue/ EPS)
--
/
-15.38%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+71.88%

Belite Bio, Inc - ADR earnings per share and revenue

On Nov 10, 2025, BLTE reported earnings of -0.65 USD per share (EPS) for Q3 25, missing the estimate of -0.49 USD, resulting in a -30.71% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.67% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.55 USD, with revenue projected to reach -- USD, implying an decrease of -15.38% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Belite Bio, Inc - ADR reported EPS of -$0.65, missing estimates by -30.71%, and revenue of $0.00, 0% as expectations.
The stock price moved up 3.67%, changed from $113.19 before the earnings release to $117.34 the day after.
The next earning report is scheduled for Mar 16, 2026.
Based on 8 analysts, Belite Bio, Inc - ADR is expected to report EPS of -$0.55 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement